PTGS2 and colorectal carcinoma: The present studies were designed to extend our previous studies to determine whether selective COX-2 inhibition with NS-398 likewise reduces CRC tumour cell proliferation and invasion/migration, and to elucidate the possible cellular and molecular mechanisms involved.